The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro

被引：1
|
作者：
Myrick, F.
Feng, J.
Svarovskaia, E.
Miller, M.
Borroto-Esoda, K.
机构：
[1] Gilead Sci Inc, Durham, NC USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
ANTIVIRAL RESEARCH | 2007年 / 74卷 / 03期
关键词：
D O I：
10.1016/j.antiviral.2007.01.091
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
83
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [41] Emtricitabine/Tenofovir Disoproxil FumarateIn Combination with a Protease Inhibitor in HIV-1 Infection
    Caroline M. Perry
    Drugs, 2009, 69 : 843 - 857
  • [42] Efavirenz/emtricitabine/tenofovir disoproxil fumarateDevelopment of drug resistant mutation in HIV-1 infection: case report
    Reactions Weekly, 2017, 1633 (1) : 300 - 300
  • [43] Cost-efectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-Infected patients
    Sanchez-de la Rosa, Rainel
    Herrera, Luis
    Moreno, Santiago
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 372 - 381
  • [44] In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women
    Anderson, Brenna L.
    Ghosh, Mimi
    Raker, Christina
    Fahey, John
    Song, Yan
    Rouse, Dwight J.
    Wira, Charles R.
    Cu-Uvin, Susan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (01)
  • [45] Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability
    Gay, Cynthia L.
    Willis, Sarah J.
    Cope, Anna B.
    Kuruc, JoAnn D.
    McGee, Kara S.
    Sebastian, Joe
    Crooks, Amanda M.
    McKellar, Mehri S.
    Margolis, David M.
    Fiscus, Susan A.
    Hicks, Charles B.
    Ferrari, Guido
    Eron, Joseph J.
    AIDS, 2016, 30 (18) : 2815 - 2822
  • [46] Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication
    Buckheit, RW
    Russell, JD
    Xu, ZQ
    Flavin, M
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (05): : 321 - 327
  • [47] A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals
    Moyle, Graeme J.
    Orkin, Chloe
    Fisher, Martin
    Dhar, Jyoti
    Anderson, Jane
    Wilkins, Edmund
    Ewan, Jacqueline
    Ebrahimi, Ramin
    Wang, Hui
    PLOS ONE, 2015, 10 (02):
  • [48] SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF NEW THIADIAZEPINDIOXIDES
    GIANNOTTI, D
    VITI, G
    NANNICINI, R
    PESTELLINI, V
    BELLAROSA, D
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (14) : 1461 - 1466
  • [49] INVITRO ANTI-HIV-1 ACTIVITY OF CHONDROITIN POLYSULFATE
    JURKIEWICZ, E
    PANSE, P
    JENTSCH, KD
    HARTMANN, H
    HUNSMANN, G
    AIDS, 1989, 3 (07) : 423 - 427
  • [50] CYCLOSPORINES - IMMUNOSUPPRESSIVE DRUGS WITH ANTI-HIV-1 ACTIVITY
    THALI, M
    MOLECULAR MEDICINE TODAY, 1995, 1 (06): : 287 - 291
12345